Key facts
- Get A Drip’s last known valuation is $34.4M (Jan 2026).
- It has raised $10.0M; the latest was Later Stage VC ($5.4M) in Jan 2026.
- Notable investors include Euroblue Investments, Jonathan Harris, Kamal Shah, Nigel Wray, Tony Buffin.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Get A Drip
- ·The full record, as it builds
Funding rounds
No funding rounds for Get A Drip are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Get A Drip
Operator of an international wellness clinic intended to provide an alternative diet supplement. The company offers in-clinic and at-home wellness services, including vitamin infusions, intramuscular injections, cryotherapy, ozone therapy, diagnostics and guided health check-ins, enabling adults seeking proactive health care to access supportive treatments and guidance that aim to enhance their physical comfort and daily energy levels
- Sector
- Healthcare
- HQ
- Letchworth, United Kingdom
- Founded
- 2016
- Employees
- 54
- Website
- getadrip.com/
- Ownership
- Privately Held (backing)
Get A Drip doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Get A Drip shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Get A Drip in its N-PORT filings yet. We sweep new filings monthly.